Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a/b trial

by Lorenz C Hofbauer, ProfMD, Richard Witvrouw, MD, Zsuzsanna Varga, MD, Naofumi Shiota, MD, Malika Cremer, PharmD, Laszlo B Tanko, MD, Daniel Rooks, PhD, Lixin Zhang Auberson, MD, Michal Arkuszewski, MD, Nathalie Fretault, MSc, Agnes Annette Schubert-Tennigkeit, MD, Dimitris A Papanicolaou, MD, Chris Recknor, MD
Published 2021-05-01